Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042731 · ClinicalTrials.gov registry record · NA
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy
A NA study of Prostate Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 5
- Study locations
NCT00042731 is a NA study of Prostate Cancer that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 79 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (87% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT00042731, a NA study of Prostate Cancer, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 5
- Study locations
Study Summary
RATIONALE: Eating a diet rich in isoflavones, compounds found in soy foods, or lycopene, a substance found in tomatoes, may keep prostate cancer from growing. Giving isoflavones or lycopene before surgery may be an effective treatment for prostate cancer. PURPOSE: Randomized clinical trial to compare the effectiveness of isoflavones with that of lycopene before surgery in treating patients who have stage I or stage II prostate cancer.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Multivitamin
- DIETARY_SUPPLEMENT Lycopene
- DIETARY_SUPPLEMENT Soy isoflavones
Study Locations (5)
Arizona
- CCOP - Western Regional, Arizona - Phoenix
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Georgia
- Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler - Savannah
North Dakota
- CCOP - MeritCare Hospital - Fargo
Texas
- CCOP - Scott and White Hospital - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2002-07 |
| Est. Completion | 2006-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00042731
The ClinicalTrials.gov registry entry for NCT00042731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (87% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Multivitamin is the first listed.
NCT00042731 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT00042731 about?
NCT00042731 is a clinical study titled "Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy". RATIONALE: Eating a diet rich in isoflavones, compounds found in soy foods, or lycopene, a substance found in tomatoes, may keep prostate cancer from growing. Giving isoflavones or lycopene before surgery may be an effective treatment for prostate cancer. PURPOSE: Randomized clinical trial to compa...
What is the current status of trial NCT00042731?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2002-07. Estimated completion is 2006-08.
What conditions does trial NCT00042731 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00042731?
The interventions under investigation include: Multivitamin (DIETARY_SUPPLEMENT), Lycopene (DIETARY_SUPPLEMENT), Soy isoflavones (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00042731?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00042731 being conducted?
This trial has 5 study locations across Arizona, Florida, Georgia, North Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.